Identification of time point to best define ‘ sub-optimal response ’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data
Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data
Eye advance online publication, June 16 2017.
doi:10.1038/eye.2017.111
Authors: I Chatziralli, M Santarelli, N Patrao, L Nicholson, M Zola, R Rajendram, P Hykin & S Sivaprasad
Source: Eye - Category: Opthalmology Authors: I Chatziralli M Santarelli N Patrao L Nicholson M Zola R Rajendram P Hykin S Sivaprasad Source Type: research